PetMed Express soars on Q2 earnings beat
PetMed Express, Inc. (PETS) is up 15.6% Monday morning. The company reported fiscal second quarter earnings of $0.52 per share on sales of $71.4 million. Analysts had forecast earnings of $0.50 per share on revenue of $72 million.
PetMed Express, Inc. (PETS) is a pet pharmacy.
Intel Corporation (INTC) and Jacobs Engineering Group Inc. (JEC) top the list of other companies with positive news today, while Bristol-Myers Squibb Company (BMY) and Hasbro, Inc. (HAS) top the list of companies with negative news.
Already a member?
Login to see your Morning News Leader Trade Idea.
Not yet a member?
You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.
Become A Member
About PetMed Express Inc.
PetMed Express Inc along with its and subsidiaries is a leading nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.